Palatin net loss narrows to $8.38 million in FY26; revenue turns to $13.19 million
Bitget2026/09/28 11:31- Palatin posted a net loss of $8.38 million, narrowing from $17.31 million a year earlier.
- Loss per share improved to $2.96 from $32.15 in the prior fiscal year.
- Revenue was $13.19 million versus no revenue a year earlier, including $9.4 million tied to Boehringer Ingelheim.
- Cash and cash equivalents rose to $7.49 million from $2.56 million at June 30, 2025; it flagged a need for additional funding.
- Phase 1 SAD/MAD for a once-weekly injectable MC4R peptide is targeted for 1H 2027, with initial data targeted in 2H 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
As the AI trading frenzy subsides, the Nvidia turmoil adds fuel to the fire! Japanese AI stocks face dual scrutiny over valuation and profitability
Investors say that Japanese stocks, which once enjoyed valuation premiums due to their exposure to the artificial intelligence (AI) sector, now seem excessively risky. The sudden resignation of Nvidia CEO Jensen Huang has further intensified market concerns about the outlook for the entire industry.

Qualcomm lays off hundreds of employees across California

Anthropic has not yet gone public, but 20 leveraged ETFs have already "jumped the gun"
More than 20 leveraged ETF products focused on Anthropic have already completed early filings in the United States prior to listing, with issuers including Direxion, ProShares, and GraniteShares. Competition is intensifying even before the IPO. First-mover advantage is critical; after SpaceX went public, out of 14 related products, only one reached assets under management of over 100 million USD. The "winner-takes-all" effect is driving issuers to rush to market.
